Evidence map›Paper›PMID 20589749›Full record

Trial reportCancer2010

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.

Alberto Broniscer, Justin N Baker, Suzanne J Baker, Susan N Chi, J Russell Geyer, E Brannon Morris, Amar Gajjar

Registry-linked trialAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05120518 (Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells), which is not on this map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05120518 recruitingnot on this mapstarted 2019, after this paper: background citation

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

TypeobservationalSponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2019 to 2029Enrolled150ConditionsPediatric CancerArmsCollection of post mortem tissue donation
3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Article
  3. An analysis of RNA quality metrics in human brain tissue.Journal of neuropathology and experimental neurology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alberto BroniscerDepartment of Oncology, St. Jude Children's Research Hospital, and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA. alberto.broniscer@stjude.org
Justin N Baker
Suzanne J Baker
Susan N Chi
J Russell Geyer
E Brannon Morris
Amar Gajjar

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
NCI NIH HHS P01 CA096832NCI NIH HHS P30 CA021765NCI NIH HHS P30 CA21765
6 · The paper itself

Abstract

backgroundBrain tissue obtained at autopsy has been used in research for non-oncologic disorders. However, to the best of the authors' knowledge, this tool has never been systematically used in large investigational studies for cancer. A prospective, multicenter study was conducted to assess the feasibility of tissue collection at autopsy and its suitability for molecular analyses in children with diffuse intrinsic pontine glioma.

methodsTumor tissue was collected at the time of diagnosis, if clinically indicated, or at autopsy. Normal brain tissue was also collected at autopsy. The integrity of DNA and RNA was evaluated in all samples. Logistic data regarding autopsies were recorded. The feasibility of tissue collection at autopsy was assessed for patients treated at a single institution over a 43-month period.

resultsTumor samples were collected at the time of diagnosis (n = 3) or at autopsy (n = 38) at 29 centers across the United States; samples were obtained at diagnosis and autopsy in 2 cases. The median interval from death to autopsy was 7.7 hours. DNA and RNA with minimal or partial degradation, which were suitable for genome-wide analysis, were obtained from 100% and 63% of tumor samples, respectively. At the coordinating institution, approximately 40% of parents consented to autopsy and 40% declined. During the study period, 12 autopsies were performed on patients who did not receive therapy at the coordinating center.

conclusionsMulticenter, biological studies based on tissue obtained at autopsy appear to be feasible in children with brain cancer. The current experience established a new paradigm for brain tissue collection, which may increase the potential for research studies in patients with cancer.

Indexed as

AutopsyPonsAdolescentBiopsyBrain NeoplasmsChildChild, PreschoolDNA, NeoplasmFeasibility StudiesGliomaHumansSpecimen HandlingDNA, Neoplasm

Identifiers

PMID20589749
PMCPMC2989604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.